Email Alert | RSS

Journal of Peking University (Health Sciences) ›› 2020, Vol. 52 ›› Issue (3): 444-450. doi: 10.19723/j.issn.1671-167X.2020.03.008

Previous Articles     Next Articles

Application of the China-PAR stroke risk equations in a rural northern Chinese population

Xun TANG1,Du-dan ZHANG2,Xiao-fei LIU1,Qiu-ping LIU1,Yang CAO1,Na LI3,Shao-ping HUANG3,Hui-dong DOU4,Pei GAO1,△(),Yong-hua HU1,△()   

  1. 1. Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China
    2. Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, United Kingdom
    3. Fangshan District Center for Disease Control and Prevention, Beijing 102446, China
    4. The First Hospital of Fangshan District, Beijing 102400, China
  • Received:2020-02-16 Online:2020-06-18 Published:2020-06-30
  • Contact: Pei GAO,Yong-hua HU E-mail:peigao@bjmu.edu.cn;yhhu@bjmu.edu.cn
  • Supported by:
    National Natural Sciences Foundation of China(81973132);National Natural Sciences Foundation of China(81961128006);National Natural Sciences Foundation of China(81872695)

RICH HTML

   

PDF (PC)

Abstract:

Objective: To validate five-year risk prediction models for stroke in a contemporary rural Northern Chinese population.Methods: Totally 6 483 rural adults aged 40 to 79 years without cardiovascular diseases were enrolled at baseline between June and August 2010, and followed up through January 2017. Expected prediction risk using the China-PAR (prediction for atherosclerotic cardiovascular disease risk in China) stroke risk equations were compared with the new Framingham stroke risk profile (FSRP). The recalibrated models were applied by adjusting the five-year baseline survival rate and the mean score to our rural northern Chinese population, while keeping other coefficient parameters the same as the original models. Kaplan-Meier analysis was used to obtain the observed event (nonfatal or fatal stroke) rate for the five years, and the expected-observed ratios were calculated to evaluate overestimation or underestimation in the cohort. The models were assessed by discrimination C statistic, calibration χ2, and calibration charts and plots for illustration as well.Results: Over an average of (5.83 ± 1.14) years of the follow-up in this validation cohort with 6 483 rural Chinese participants, 438 subjects deve-loped a first stroke event. Recalibrated China-PAR stroke risk equations and FSRP well-performed for predicting five-year stroke risk in men, and had C statistics of 0.709 (95%CI, 0.675 - 0.743) and 0.721 (95%CI, 0.688 - 0.754), with calibration χ2 values being 5.7 (P = 0.770) and 13.6 (P = 0.137), respectively. However, both China-PAR and FSRP overestimated stroke events by 11.6% and 30.0% in women, and had C statistics of 0.713 (95%CI, 0.684-0.743) and 0.710 (95%CI, 0.679-0.740), respectively. Calibration χ2 values in women were 12.5 (P = 0.188) for China-PAR and 24.0 (P = 0.004) for FSRP. In addition, the calibration charts and plots illustrated good agreement between the observations and the predictions only in the China-PAR stroke risk equations, especially for men.Conclusion: In this validation cohort of rural northern Chinese adults, the China-PAR models had better performance of five-year stroke risk prediction than the FSRP, indicating that recalibrated China-PAR stroke risk equations might be appropriate tools for risk assessment and primary prevention of stroke in China.

Key words: Stroke, Risk prediction, Cohort study, Rural population

CLC Number: 

  • R181.2

Figure 1

Flow chart of inclusion criteria applied to the study participants for the validation of five-year stroke risk prediction models CHD, coronary heart disease; SBP, systolic blood pressure."

Table 1

Baseline characteristics and stroke events of study participants by gender"

Characteristics Men
(n=2 215)		 Women
(n=4 268)		 P value
Age/years, x?±s 55.7 ± 9.0 55.2 ± 8.7 0.027
Current smoker, n (%) 1 310 (59.1) 430 (10.1) <0.001
Waist circumference/cm, x?±s 87.1 ± 10.5 84.2 ± 10.2 <0.001
SBP/mmHg, x?±s 128.9 ± 16.4 128.0 ± 17.1 0.037
DBP/mmHg, x?±s 82.2 ± 9.9 79.9 ± 9.1 <0.001
Anti-hypertensive treatment, n (%) 344 (15.5) 749 (17.6) 0.039
Total cholesterol/ (mg/dL)a, x?±s 180.9 ± 36.8 194.2 ± 37.8 <0.001
HDL-C/ (mg/dL) a, x?±s 44.5 ± 11.6 47.3 ± 11.4 <0.001
Diabetes mellitus, n (%) 192 (8.7) 421 (9.9) 0.119
Atrial fibrillation, n (%) 21 (1.0) 23 (0.5) 0.057
Parental history of stroke, n (%) 475 (21.4) 986 (23.1) 0.130
Incident stroke events, n (%) 202 (9.7) 236 (6.1) <0.001
Incidence of stroke /100 000 person-years 1 653.5 1 008.4
5-year Kaplan-Meier stroke rate /% 6.1 3.8

Table 2

External validation of five-year stroke risk prediction by China-PAR and comparison with the FSRP"

Items Men Women
China-PAR FSRP China-PAR FSRP
Total participants, n 2 215 2 215 4 268 4 268
Actual stroke eventsa , n 202 202 236 236
Kaplan-Meier-adjusted eventsb , n 136.1 136.1 163.5 163.5
Predicted stroke eventsc , n 130.3 125.6 182.4 212.5
Expected-observed ratio 0.957 0.923 1.116 1.300
C statistic 0.709 0.721 0.713 0.710
95%CI 0.675-0.743 0.688-0.754 0.684-0.743 0.679-0.740
Calibration χ2 5.7 13.6 12.5 24.0
P value 0.770 0.137 0.188 0.004

Figure 2

Kaplan-Meier observed and predicted five-year stroke event rates in the external validation cohort using the China-PAR and FSRP China-PAR, prediction for atherosclerotic cardiovascular disease Risk in China; FSRP, Framingham Stroke Risk Profile."

Figure 3

Calibration plots for the external validation of five-year stroke risk prediction using the China-PAR and FSRP China-PAR, prediction for atherosclerotic cardiovascular disease risk in China; FSRP, Framingham stroke risk profile."

[1] GBD 2016 lifetime risk of stroke collaborators. Global, regional, and country-specific lifetime risks of stroke, 1990 and 2016BD 2016 lifetime risk of stroke collaborators. Global, regional, and country-specific lifetime risks of stroke, 1990 and 2016[J]. N Engl J Med, 2018,379(25):2429-2437.
[2] Zhou M, Wang H, Zeng X, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990—2017: a systematic analysis for the global burden of disease study 2017[J]. Lancet, 2019,394(10204):1145-1158.
[3] Lloyd-Jones DM, Braun LT, Ndumele CE, et al. Use of risk assessment tools to guide decision-making in the primary prevention of atherosclerotic cardiovascular disease: a special report from the American Heart Association and American College of Cardiology[J]. Circulation, 2019,139(25):e1162-e1177.
pmid: 30586766
[4] Dufouil C, Beiser A, McLure LA, et al. Revised Framingham stroke risk profile to reflect temporal trends[J]. Circulation, 2017,135(12):1145-1159.
[5] Xing X, Yang X, Liu F, et al. Predicting 10-year and lifetime stroke risk in Chinese population[J]. Stroke, 2019,50(9):2371-2378.
pmid: 31390964
[6] 唐迅, 何柳, 曹洋, 等. 基于农村社区人群的心血管危险因素相对效应和性别差异的分层研究[J]. 北京大学学报(医学版), 2011,43(3):379-385.
[7] 唐迅, 张杜丹, 何柳, 等. China-PAR模型在北方农村人群中预测动脉粥样硬化性心血管疾病发病风险的应用[J]. 北京大学学报(医学版), 2017,49(3):439-445.
[8] Alba AC, Agoritsas T, Walsh M, et al. Discrimination and calibration of clinical prediction models: users’ guides to the medical literature[J]. JAMA, 2017,318(14):1377-1384.
pmid: 29049590
[9] Cook NR, Ridker PM. Calibration of the pooled cohort equations for atherosclerotic cardiovascular disease: an update[J]. Ann Intern Med, 2016,165(11):786-794.
pmid: 27723890
[10] 中国心血管病风险评估和管理指南编写联合委员会. 中国心血管病风险评估和管理指南[J]. 中华预防医学杂志, 2019,53(1):13-35.
[11] Flueckiger P, Longstreth W, Herrington D, et al. Revised Framingham stroke risk score, nontraditional risk markers, and incident stroke in a multiethnic cohort[J]. Stroke, 2018,49(2):363-369.
doi: 10.1161/STROKEAHA.117.018928 pmid: 29311270
[12] Bos D, Ikram MA, Leening MJG, et al. The revised Framingham stroke risk profile in a primary prevention population: the Rotterdam study[J]. Circulation, 2017,135(22):2207-2209.
pmid: 28559499
[1] Yulin WANG, Xin GAO, Zhike LIU, Siyan ZHAN. Epidemiological characteristics of intussusception in children aged 0-3 years in Jiangsu Province from 2018 to 2023 [J]. Journal of Peking University (Health Sciences), 2026, 58(3): 490-495.
[2] Jingxian WU, Liuyan ZHENG, Huan YU, Huairong WANG, Shuting XIE, Yalin CHEN, Teng LI, Mengying WANG, Xueying QIN, Tao WU, Dafang CHEN, Yiqun WU, Yonghua HU. Association analysis between genetic nurturing effects of CTNNA gene family and ischemic stroke [J]. Journal of Peking University (Health Sciences), 2026, 58(3): 528-535.
[3] Qingwei MENG, Meng FAN, Huangda GUO, Hanyu ZHANG, Mengying WANG, Siyue WANG, Hexiang PENG, Xueheng WANG, Tianjiao HOU, Xueying QIN, Dafang CHEN, Jing LI, Yiqun WU, Tao WU, Hongbo CHEN, Yonghua HU. Prognostic analysis of anticoagulation therapy in elderly patients with cardioembolic stroke [J]. Journal of Peking University (Health Sciences), 2026, 58(3): 536-542.
[4] Mengxi LU, Binghan WANG, Jiali KANG, Qiuping LIU, Yifan ZHOU, Yexiang SUN, Peng SHEN, Hongbo LIN, Xun TANG, Pei GAO. Application of biological age for cardiovascular risk prediction in a community-based Chinese cohort [J]. Journal of Peking University (Health Sciences), 2026, 58(3): 543-550.
[5] Mengxi LU, Qiuping LIU, Tianjing ZHOU, Xiaofei LIU, Yexiang SUN, Peng SHEN, Hongbo LIN, Xun TANG, Pei GAO. Association of triglyceride-glucose index and cardiovascular disease in a community-based Chinese cohort [J]. Journal of Peking University (Health Sciences), 2025, 57(3): 430-435.
[6] Kun WANG, Huairong WANG, Huan YU, Ruotong YANG, Liuyan ZHENG, Jingxian WU, Xueying QIN, Tao WU, Dafang CHEN, Yiqun WU, Yonghua HU. Identifying genetic etiology of ischemic stroke based on pleiotropy of obesity related genes: A sibling study [J]. Journal of Peking University (Health Sciences), 2025, 57(3): 448-455.
[7] Huan YU,Ruo-tong YANG,Si-yue WANG,Jun-hui WU,Meng-ying WANG,Xue-ying QIN,Tao WU,Da-fang CHEN,Yi-qun WU,Yong-hua HU. Metformin use and risk of ischemic stroke in patients with type 2 diabetes: A cohort study [J]. Journal of Peking University (Health Sciences), 2023, 55(3): 456-464.
[8] Yun-jing ZHANG,Li-ying QIAO,Meng QI,Ying YAN,Wei-wei KANG,Guo-zhen LIU,Ming-yuan WANG,Yun-feng XI,Sheng-feng WANG. Development and validation of risk prediction model for new-onset cardiovascular diseases among breast cancer patients: Based on regional medical data of Inner Mongolia [J]. Journal of Peking University (Health Sciences), 2023, 55(3): 471-479.
[9] Ruo-tong YANG,Meng-ying WANG,Chun-nan LI,Huan YU,Xiao-wen WANG,Jun-hui WU,Si-yue WANG,Jia-ting WANG,Da-fang CHEN,Tao WU,Yong-hua HU. Interaction between ischemic stroke risk loci identified by genome-wide association studies and sleep habits [J]. Journal of Peking University (Health Sciences), 2022, 54(3): 412-420.
[10] Yu-han DENG,Yong JIANG,Zi-yao WANG,Shuang LIU,Yu-xin WANG,Bao-hua LIU. Long short-term memory and Logistic regression for mortality risk prediction of intensive care unit patients with stroke [J]. Journal of Peking University (Health Sciences), 2022, 54(3): 458-467.
[11] LIU Jie,GUO Chao. A prospective cohort study of the influence of positive/negative effectivity on the mortality risk of the Chinese elderly [J]. Journal of Peking University (Health Sciences), 2022, 54(2): 255-260.
[12] WU Jun-hui,WU Yi-qun,WU Yao,WANG Zi-jing,WU Tao,QIN Xue-ying,WANG Meng-ying,WANG Xiao-wen,WANG Jia-ting,HU Yong-hua. Incidence and risk factors of ischemic stroke in patients with type 2 diabetes among urban workers in Beijing, China [J]. Journal of Peking University (Health Sciences), 2022, 54(2): 249-254.
[13] REN Guo-yong,WU Xue-mei, ,LI Jie-yu,SUN Wei-ping,HUANG Yi-ning. Susceptibility vessel sign in subacute stroke patients with large vessel occlusion [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1133-1138.
[14] Ya-fei LIU,Lin-lin SONG,Mao-wei XING,Li-xin CAI,Dong-xin WANG. Comparison of pulse pressure variation, stroke volume variation, and plethysmographic variability index in pediatric patients undergoing craniotomy [J]. Journal of Peking University (Health Sciences), 2021, 53(5): 946-951.
[15] Yue HOU,Xu-tong ZHAO,Zhi-ying XIE,Yun YUAN,Zhao-xia WANG. Mitochondrial encephalopathy, lactic acidosis and stroke-like episodes / myoclonus epilepsy with ragged-red fibers /Leigh overlap syndrome caused by mitochondrial DNA 8344A>G mutation [J]. Journal of Peking University (Health Sciences), 2020, 52(5): 851-855.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright © Journal of Peking University (Health Sciences), All Rights Reserved.
Powered by Beijing Magtech Co. Ltd